Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 8 Jul 21 EFFECT Notice of effectiveness
- 7 Jul 21 424B3 Prospectus supplement
- 2 Jul 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
18 Jun 21 S-4 Registration of securities issued in business combination transactions
RPRX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 24, 2021, with respect to the consolidated financial statements of Royalty Pharma plc and subsidiaries, in the Registration Statement (Form S-4) and related Prospectus of Royalty Pharma plc for the registration of its senior notes.
/s/ Ernst & Young
Dublin, Ireland
June 17, 2021